Donald R Mattison

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc Environmental exposures and development
    Donald R Mattison
    Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA
    Curr Opin Pediatr 22:208-18. 2010
  2. pmc Pubertal delay in male nonhuman primates (Macaca mulatta) treated with methylphenidate
    Donald R Mattison
    Epidemiology Branch, Division of Epidemiology, Statistics, and Prevention Research, The Eunice Kennedy Shriver National Institute for Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA
    Proc Natl Acad Sci U S A 108:16301-6. 2011
  3. ncbi request reprint Newborns and drug studies: the NICHD/FDA newborn drug development initiative
    George P Giacoia
    Obstetric and Pediatric Pharmacology Branch, Center for Research for Mothers and Children, National Institute of Child Health and Human Development, National Institutes of Health, Rockville, MD, USA
    Clin Ther 27:796-813. 2005
  4. ncbi request reprint The newborn drug development initiative
    George P Giacoia
    Obstetric and Pediatric Pharmacology Branch, Center for Research for Mothers and Children, National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland
    Pediatrics 117:S1-8. 2006
  5. ncbi request reprint Selected Proceedings of the NICHD/FDA newborn drug development initiative: Part II
    George P Giacoia
    Obstetric and Pediatric Pharmacology Branch, Center for Research for Mothers and Children, National Institute of Child Health and Human Development, National Institutes of Health, Rockville, Maryland 20847, USA
    Clin Ther 28:1337-41. 2006
  6. pmc Methylphenidate and amphetamine do not induce cytogenetic damage in lymphocytes of children with ADHD
    Kristine L Witt
    National Toxicology Program, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Triangle Park, NC 27709, USA
    J Am Acad Child Adolesc Psychiatry 47:1375-83. 2008

Detail Information

Publications6

  1. pmc Environmental exposures and development
    Donald R Mattison
    Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA
    Curr Opin Pediatr 22:208-18. 2010
    ....
  2. pmc Pubertal delay in male nonhuman primates (Macaca mulatta) treated with methylphenidate
    Donald R Mattison
    Epidemiology Branch, Division of Epidemiology, Statistics, and Prevention Research, The Eunice Kennedy Shriver National Institute for Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA
    Proc Natl Acad Sci U S A 108:16301-6. 2011
    ..Regardless, deficits in testicular volume and hormone secretion disappeared over the 40-mo observation period, suggesting that the impact of MPH on puberty is not permanent...
  3. ncbi request reprint Newborns and drug studies: the NICHD/FDA newborn drug development initiative
    George P Giacoia
    Obstetric and Pediatric Pharmacology Branch, Center for Research for Mothers and Children, National Institute of Child Health and Human Development, National Institutes of Health, Rockville, MD, USA
    Clin Ther 27:796-813. 2005
    ..Progress has been made in research on the effects of drug therapy on pediatric patients, but neonates are still an understudied population. Those most likely to receive drug therapy (eg, preterm infants) are least likely to be studied...
  4. ncbi request reprint The newborn drug development initiative
    George P Giacoia
    Obstetric and Pediatric Pharmacology Branch, Center for Research for Mothers and Children, National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland
    Pediatrics 117:S1-8. 2006
    ....
  5. ncbi request reprint Selected Proceedings of the NICHD/FDA newborn drug development initiative: Part II
    George P Giacoia
    Obstetric and Pediatric Pharmacology Branch, Center for Research for Mothers and Children, National Institute of Child Health and Human Development, National Institutes of Health, Rockville, Maryland 20847, USA
    Clin Ther 28:1337-41. 2006
    ..Working groups were established in 3 therapeutic areas: the central nervous, pulmonary, and cardiovascular systems. Three additional groups discussed pain control, drug prioritization, and ethics in neonatal clinical trials...
  6. pmc Methylphenidate and amphetamine do not induce cytogenetic damage in lymphocytes of children with ADHD
    Kristine L Witt
    National Toxicology Program, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Triangle Park, NC 27709, USA
    J Am Acad Child Adolesc Psychiatry 47:1375-83. 2008
    ....